BlackRock, Inc. 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 11:44 am Purchase | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 3,406,072 7.100% | 37,915 (+1.13%) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 3,368,157 7.100% | 835,515 (+32.99%) | Filing |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 2,532,642 5.400% | 854,735 (+50.94%) | Filing |
| 2023-03-08 2:15 pm Sale | 2023-02-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 1,677,907 4.600% | -458,770 (-21.47%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 2,136,677 5.800% | 2,136,677 (New Position) | Filing |